|
Study | N | Antibiotic regimen | Gestational age at treatment (wks) | Days treatment | Primary outcomes | Benefit |
|
Hauth et al. (1995) [53] | 624 | PO metronidazole + PO erythromycin | 22–24 | 7/14 | Gestational age at delivery Rate of preterm delivery | Yes (26% versus 36% rate of preterm delivery, ) |
McDonald et al. (1997) [54] | 897 | PO metronidazole | 24–29 | 2 doses | Reduction in Spontaneous birth less than 37 weeks | Yes (9.1% versus 41.7% reduction, OR 0.14, CI 0.01–0.84) |
Carey et al. (2000) [67] | 1953 | PO metronidazole | 16–24 24–30 | 2 doses | Rate of delivery before 37 weeks | No |
Ugwumadu et al. (2003) [56] | 6210 | PO clindamycin | 12–22 | 5 | Spontaneous preterm delivery and late miscarriage | Yes (10.4% reduction in miscarriages and PTD,) |
|
Trichomonas vaginalis | | | | | | |
Klebanoff et al. (2001) [55] | 617 | PO metronidazole | 16–23 24–29 | 2 doses | Rate of delivery before 37 weeks | No |
Kigozi et al. (2003) [57] | 206 | PO azithromycin, cefixime, metronidazole | Any gestation | 1 dose | (1) Birth weight (2) Rate of preterm birth (3) 2-year mortality rate | No |
|
Other relevant studies | | | | | | |
Interconception Andrews et al. (2006) [69] | 124 | PO azithromycin + PO metronidazole | 4 months after delivery | 2 doses/7 days every 4 months until next pregnancy | Subsequent rate of preterm birth or miscarriage | No |
Fetal Fibronectin + Andrews et al. (2003) [58] | 703 | PO metronidazole + PO erythromycin | 21–25.6
| 10 | Spontaneous delivery less than 37 weeks | No |
Fetal Fibronectin + Shennan et al. (2006) [59] | 109 | PO metronidazole | 24–27 | 7 | Spontaneous preterm delivery less than 30 weeks | No |
|